Phibro Animal Health Corporation updated earnings guidance for the year 2024. For the fiscal year 2024, the company expects net sales of $980 million to $1.020 billion. The company have updated fiscal year 2024 guidance for the following measures: Net income of $7 million to $12 million and Diluted EPS of $0.17 to $0.30.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.16 USD | +0.23% | -2.67% | +48.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.19% | 695M | |
-10.36% | 80.73B | |
+22.21% | 9B | |
+24.50% | 3.69B | |
+0.97% | 3.28B | |
-0.20% | 1.31B | |
-26.00% | 1.23B | |
-29.34% | 1.18B | |
-23.11% | 1B | |
+1.54% | 932M |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024